Skip to main content

Table 5 30-day outcomes

From: Long-term results after mitral valve surgery using minimally invasive versus sternotomy approach: a propensity matched comparison of a large single-center series

  MIC (N = 422) CS (N = 422) p value Unadjusted OR Adjusted OR*
n/N % n/N %
Death 11/422 2.6 19/422 4.5 0.137 0.568 (0.267–1.208) 0.893 (0.370–2.156)
Cardiovascular death 5/422 1.2 16/422 3.8 0.015 0.304 (0.110–0.838) 0.402 (0.130–1.247)
Non-CV death 6/422 1.4 3/422 0.7 0.505 2.014 (0.500–8.108) 4.839 (0.952–24.595)
Stroke 9/422 2.1 16/422 3.8 0.155 0.553 (0.242–1.266) 0.524 (0.204–1.342)
Acute renal failure 9/422 2.1 50/422 11.9 < 0.001 0.162 (0.079–0.334) 0.221 (0.101–0.482)
Myocardial infarction 3/422 0.7 0 0 0.249 n.a n.a
Pacemaker implantation 14/422 3.3 47/422 11.2 < 0.001 0.273 (0.148–0.504) 0.307 (0.155–0.608)
Repeat MV surgery 1/422 0.2 3/422 0.7 0.624 0.332 (0.034–3.202) 0.825 (0.059–11.464)
  1. p values and OR that are statistically significant are highlighted in bold
  2. *Adjusted for procedural differences between the two groups: MV repair, MV replacement, Cryoablation, LAA closure, concomitant TVR; CV cardiovascular, MV mitral valve